• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Humana Inc.

    3/7/25 7:36:05 AM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email
    DEFA14A 1 d852577ddefa14a.htm DEFA14A DEFA14A

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a)

    of the Securities Exchange Act of 1934

    (Amendment No. )

    Filed by the Registrant  ☒

    Filed by a Party other than the Registrant  ☐

    Check the appropriate box:

     

    ☐   Preliminary Proxy Statement

      

    ☐ CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2))

    ☐   Definitive Proxy Statement

    ☒   Definitive Additional Materials

    ☐   Soliciting Material Pursuant to §240.14a-12

    Humana Inc.

     

    (Name of Registrant as Specified In Its Charter)

     

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No fee required.

     

    ☐

    Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

     

      (1)

    Title of each class of securities to which transaction applies:

     

     

      (2)

    Aggregate number of securities to which transaction applies:

     

     

      (3)

    Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

     

     

      (4)

    Proposed maximum aggregate value of transaction:

     

     

      (5)

    Total fee paid:

     

     

     

    ☐

    Fee paid previously with preliminary materials.

     

    ☐

    Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

     

      (1)

    Amount Previously Paid:

     

     

      (2)

    Form, Schedule or Registration Statement No.:

     

     

      (3)

    Filing Party:

     

     

      (4)

    Date Filed:

     

     


    On March 7, 2025, Humana Inc. (the “Company”) made the following communication available to the Company’s employees:

    Highlights

     

      •  

    You may have the right to vote on items being presented at our Annual Meeting of Stockholders (the “Annual Meeting”)

     

      •  

    The Company’s Annual Meeting is scheduled for April 17, 2025 at 1:00 p.m. Eastern Time, and will be held via a live audio webcast accessible at: www.virtualshareholdermeeting.com/HUM2025

    Exercise your voting privilege as a Humana stockholder

    Humana associates who participate in our Company’s Retirement Savings Plan 401(k) and have invested funds in the Humana Common Stock Fund have the right to vote on items being presented at this year’s Annual Meeting, scheduled for April 17, 2025. You may submit one vote for each share held in your Humana Common Stock account as of February 28, 2025, the record date for this Annual Meeting.

    What documents do you need to vote?

    Every year, Humana produces a document - the proxy statement - that details all of the information the Company’s stockholders need in order to make informed votes. The proxy becomes available to stockholders and the public after Humana files it with the federal Securities and Exchange Commission on March 7, 2025. In order to vote, you must also receive an official “voting card.”

    When will you receive the proxy statement and voting card?

    Starting March 7, 2025, all stockholders who have (recently or in prior years) successfully submitted electronic requests for a proxy statement and voting card will then receive - via the e-mail address you designated during the online-registration process - a proxy statement and voting card. (Please watch for e-mail from [email protected].) If you did not sign up for electronic delivery of these materials, you’ll receive a “Notice and Access Card” in the mail at home regarding the material.

    When can participants in the Humana Retirement Savings Plan vote?

    If you wish to vote, you may do so AFTER you receive your voting card. You then must vote BEFORE 11:59 p.m., EDT on Wednesday, April 9, 2025, through Humana’s Retirement Savings Plan Trustee - Charles Schwab - with Broadridge acting as tabulator. If your voting instructions are received by 11:59 p.m. EDT on Wednesday, April 9, 2025, the Trustee will submit a proxy that reflects your instructions. If you do not give voting instructions (or give them late), the Trustee will vote your interest in the Humana Common Stock Fund in the same proportion as the shares attributed to the Humana Retirement Savings Plan actually voted. Humana’s Annual Meeting will be held on April 17, 2025.

    Whom do you contact for answers to your stockholder-voting-process questions?

    If you have any questions, please contact Joseph M. Ruschell, Corporate Secretary via email at [email protected].

    On March 7, 2025, the Company distributed the following “Notice Regarding the Availability of Proxy Materials” to its stockholders as of the record date of February 28, 2025.


    LOGO

     

    You invested in HUMANA INC. and it’s time to vote!

    You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on April 17, 2025.

    Get informed before you vote

    View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 3, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

     

    LOGO

     

     

    *Please check the meeting materials for any special requirements for meeting attendance.


    Vote at www.ProxyVote.com

     

     

    THIS IS NOT A VOTABLE BALLOT

     

    This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

      

     

     

      Voting Items

     

     

    Board

    Recommends

     
      1.    Election of Directors  
     
       Nominees:  

      1a.

       Raquel C. Bono, M.D.   LOGO  For
     

      1b.

       Frank A. D’Amelio   LOGO  For
     

      1c.

       David T. Feinberg, M.D.   LOGO  For
     

      1d.

       Wayne A. I. Frederick, M.D.   LOGO  For
     

      1e.

       John W. Garratt   LOGO  For
     

      1f.

       Kurt J. Hilzinger   LOGO  For
     

      1g.

       Karen W. Katz   LOGO  For
     

      1h.

       Marcy S. Klevorn   LOGO  For
     

      1i.

       Jorge S. Mesquita   LOGO  For
     

      1j.

       James A. Rechtin   LOGO  For
     

      1k.

       Gordon Smith   LOGO  For
     

      2.

       The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm.   LOGO  For
     

      3.

       Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement.   LOGO  For
      At their discretion, the Proxies are authorized to vote upon any other matters as may come before the Annual Meeting.    
        

     

    Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.

     

    V62002-P24548

    Get the next $HUM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    2/2/2026$174.00Equal-Weight → Underweight
    Morgan Stanley
    1/7/2026$290.00Overweight → Equal Weight
    Wells Fargo
    12/5/2025$313.00Hold → Buy
    Jefferies
    10/14/2025$235.00Sell
    Goldman
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Martin Aaron claimed no ownership of stock in the company (SEC Form 3)

    3 - HUMANA INC (0000049071) (Issuer)

    1/27/26 9:30:40 AM ET
    $HUM
    Medical Specialities
    Health Care

    President & CEO Rechtin James A. converted options into 2,183 units of Humana Common and covered exercise/tax liability with 980 units of Humana Common (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    1/12/26 9:42:43 AM ET
    $HUM
    Medical Specialities
    Health Care

    Director Feinberg David T was granted 766 units of Humana Common, increasing direct ownership by 174% to 1,207 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    1/5/26 2:29:49 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    Humana Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    2/11/26 6:40:24 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form S-8 POS filed by Humana Inc.

    S-8 POS - HUMANA INC (0000049071) (Filer)

    12/19/25 4:57:12 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    12/16/25 8:05:45 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Named KCTCS Education First Employer, Announces Humana Scholars Program for Nursing Students

    Humana is investing in a new program with Jefferson Community and Technical College to strengthen and support Kentucky's nursing workforce. In announcing the launch of the Humana Scholars program, Humana joins the Kentucky Community and Technical College System (KCTCS) network of Education First Employers, partnering with the system's Louisville campus, Jefferson. Humana is investing a total of $125,000 in the Humana Scholars program, which includes two components – a Scholarship Fund and a Student Support Fund – to help train and support a pipeline of skilled nurses. The program will offer both scholarships and help reduce barriers, like food insecurity or lack of transportation, for f

    2/5/26 10:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Report Finds Value-Based Care Improves Outcomes for Medicare Advantage Members

    Medicare Advantage members in value-based care arrangements had 24.3% fewer inpatient hospital admissions than those in Original Medicare in 2024. Humana Medicare Advantage members receiving value-based care had 13.4% fewer emergency department visits and 7.6% fewer hospital admissions than members in non-value-based care arrangements. Medicare Advantage members receiving value-based care reported higher satisfaction with their care, including a 13-point higher Net Promoter Score than those using fee-for-service. Humana Inc. (NYSE:HUM), a health and well-being company focused on helping people live their healthiest lives, today released its latest Value-Based Care By the Numbers

    2/4/26 8:45:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Humana downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Humana from Equal-Weight to Underweight and set a new price target of $174.00

    2/2/26 6:49:06 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Humana from Overweight to Equal Weight and set a new price target of $290.00

    1/7/26 8:56:48 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana upgraded by Jefferies with a new price target

    Jefferies upgraded Humana from Hold to Buy and set a new price target of $313.00

    12/5/25 8:31:42 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

    Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of

    2/11/26 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 4Q25 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BIb3f01f81dd3b4f7cb8331d38dad89

    1/9/26 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    AM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Humana Inc. (Humana). AM Best also has affirmed the Short-Term Issue Credit Rating of AMB-2 (Satisfactory) for Humana. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of Humana Health Group

    12/16/25 5:31:00 PM ET
    $HUM
    Medical Specialities
    Health Care